'Cancer patients, brace yourselves. Many new drug treatments cost nearly $100,000 a year, sparking fresh debate about how much a few months more of life is worth.
The latest is Provenge, a first-of-a-kind therapy approved in April. It costs $93,000 and adds four months' survival, on average, for men with incurable prostate tumors. Bob Svensson is honest about why he got it: insurance paid. "I would not spend that money," because the benefit doesn't seem worth it, says Svensson, 80, a former corporate finance officer from Bedford, Mass...Read more:
Welcome to "A Light In The Darkness" - a realm that explores the mysterious and the occult; the paranormal and the supernatural; the unexplained and the controversial; and, not forgetting, of course, the conspiracy theories; including Artificial Intelligence; Chemtrails and Geo-engineering; 5G and EMR Hazards; The Global Warming Debate; Trans-Humanism and Trans-Genderism; The Covid-19 and mRNA vaccine issues; The Ukraine Deception ... and a whole lot more.